[MEDIA]
[IMG] We at Stallion Asset are keen watcher of trends around the globe, though we completely missed the Bitcoin Trend even after it always met...
Reliance Nippon Life Asset Management company is coming up with an IPO, and the market seems super Excited about Financialization of Savings as a...
[IMG] Last Week we met the Management of PNB Housing and spend the entire day with the whole top management. We got amazing insights about the...
[IMG] Today I want to Share a Secret with you. A Secret that will help you successfully Invest in the Market. Lately Markets have been in a strong...
ICICI Lombard IPO Published September 12, 2017 Total Comments : 0 [IMG] Last week we Attended the Analyst Meet of ICICI Lombard which will be...
Last week I met the management of Shakti Pump, the stock has moved up 250% in last 6 months and there is a lot of hype as management has guided...
Yesterday my team at Stallion Asset & I attended the Edelweiss Investor Day meet, and these are the 5 main take away’s from the meet 1)The Larger...
[MEDIA] The Conservative Fair Value of Reliance Capital is 1111, using SOTP Method. Reliance Capital has 5 main Business' 1. Asset management –...
[MEDIA] Yesterday i attended a CFA Conference where speaker was Midcap Moghul kenneth Andrade and his investment philosophy is pretty simple “If...
Do watch the video to know Stallion Asset's unbiased views going forward. [MEDIA]
Stallion Asset is popular for catching long term trends but here is one sector where contrarian Investors can look at. What Doesn’t kill you...
The Market is very excited with New NBFC Aditya Birla Financial Services (New Name – Aditya Birla Capital) coming on the block soon, with PI...
Read our entire report and see if you can subscribe for listing gains. Below is the link...
Here is the link to the report. https://www.stallionasset.com/blog/cdsl-research/
There is no doubt that financial Services and NBFC’s have been the leader of this Bull Market. IDFC is one of the newest bank and has recently...
[IMG] This was a view point written by Amit Jeswani of Pharma Index last year in August 2016. He has got it spot on. Do read....
Separate names with a comma.